Thank you, Satya, and welcome, everyone. I will open today's call with a recap of the fiscal second quarter 2020 financial results. Richard will then provide an update on the business. Afterwards, we'll open the call for questions. Revenues for the second quarter of fiscal 2020 were $8.3 million compared with $10.2 million in the second fiscal quarter of 2019. The COVID-19 outbreak partially impacted the acceptance testing and delivery of 2 orders with a total value of approximately $1.6 million. Virtual acceptance testing and partial deliveries were completed in April, with the balance scheduled to ship this quarter. Gross profit was $4.3 million or 48.4% of revenue. The decrease in gross profit margin compared to last year was driven by $77,000 of additional engineering charges resulting from the use of a more precise process to charge engineering expenses to cost of sales. Excluding this additional cost, gross profit as a percentage of sales this quarter would have been 49.4% compared to 50.9% in the prior year. And for first 6 months of the fiscal year, gross profit would have been 50.9% compared to 50.5% for the same prior year period. Operating expenses in the fiscal second quarter of 2020 were $3.7 million, essentially flat compared to the same period last year. Selling and general administrative expenses increased this year as we added employees and increased sales and marketing activities. Research and development expense decreased compared to the same period last year as hardware development cost decreased and some costs were charged to cost of sales, offset by continued increases in software development. We generated net income of $302,000 or $0.01 per diluted share in the fiscal second quarter compared with net income of $1.2 million or $0.04 per diluted share in the same quarter last year. Cash used in operating activities in the quarter was $345,000. This is largely due to increased inventory at the end of the quarter, offset by net income and noncash charges. And last year's similar quarter, operations provided $4.2 million. Our balance sheet remains strong. Cash and cash equivalents at March 31, 2020, were $16.4 million compared to $18.8 million at September 30, 2019. The $2.4 million decrease in cash and cash equivalents was due to the cash used in operating activities in the year-to-date. Working capital increased by $0.7 million to $25.5 million at March 31, 2020, compared to $24.8 million at September 30, 2019. The increase was primarily the result of net income generated this year. During this year's second fiscal quarter, we used $400,000 to repurchase 156,000 shares of company stock. Last year, the Board authorized a $5 million repurchase program through December 31, 2020, of which $4.1 million is still available. With that, I would like to turn the call over to Richard.